Alkem Launches Generic Diabetes Drug Empanorm in India
Alkem Laboratories has launched a generic medication for type-2 diabetes, chronic kidney disease and heart failure in India under the brand name Empanorm, offering prices 80% lower than innovator products.
New Delhi, Mar 12 (PTI) Alkem Laboratories on Wednesday said it has launched a generic medication for the treatment of type-2 diabetes mellitus, chronic kidney disease and chronic heart failure.
The company has introduced the generic empagliflozin and its combinations in India under the brand name Empanorm at prices 80 per cent lower than the innovator products, Alkem Laboratories said in a statement.
Empagliflozin is an SGLT-2 (Sodium-Glucose Co-Transporter-2) inhibitor indicted for use in the treatment of type-2 diabetes mellitus, chronic kidney disease and chronic heart failure.
"This globally-accepted molecule has transformed diabetes care with its additional benefits in managing chronic kidney disease and cardiovascular health," Alkem CEO Vikas Gupta said.
Leveraging Alkem's strong distribution network, the drug firm aims to make this therapy widely available, enhancing treatment accessibility and improving health outcomes for patients across the country, he added.
Shares of Alkem Laboratories were trading 1.32 per cent down at Rs 4,712.70 apiece on BSE.
The company has introduced the generic empagliflozin and its combinations in India under the brand name Empanorm at prices 80 per cent lower than the innovator products, Alkem Laboratories said in a statement.
Empagliflozin is an SGLT-2 (Sodium-Glucose Co-Transporter-2) inhibitor indicted for use in the treatment of type-2 diabetes mellitus, chronic kidney disease and chronic heart failure.
"This globally-accepted molecule has transformed diabetes care with its additional benefits in managing chronic kidney disease and cardiovascular health," Alkem CEO Vikas Gupta said.
Leveraging Alkem's strong distribution network, the drug firm aims to make this therapy widely available, enhancing treatment accessibility and improving health outcomes for patients across the country, he added.
Shares of Alkem Laboratories were trading 1.32 per cent down at Rs 4,712.70 apiece on BSE.
You May Like To Read
TODAY'S MOST TRADED COMPANIES
- Company Name
- Price
- Volume
- Vodafone-Idea-L
- 11.65 (+ 3.56)
- 106772451
- Alstone-Textiles
- 0.28 ( -3.45)
- 44187760
- Mangalam-Industrial
- 0.88 ( -2.22)
- 39177573
- Sunshine-Capital
- 0.27 (+ 3.85)
- 35956340
- GMR-Airports
- 104.40 (+ 6.37)
- 30453005
MORE NEWS
© 2025 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback